Adipotide (FTPP) 10mg
Extended Adipotide for Comprehensive Targeted Fat Research
The 10mg Adipotide vial provides extended research supply for comprehensive targeted adipose apoptosis and vascular targeting studies.
Extended Adipotide for Comprehensive Targeted Fat Research
Double the 5mg format for complete Adipotide mechanism, dose-response, and long-duration fat tissue reduction research.
As one of the most studied compounds in the metabolic & fat loss research space, Adipotide has attracted sustained scientific interest across Comprehensive targeted fat research, Extended adipose vascular studies. Peer-reviewed evidence indicates that double supply for comprehensive research, which has positioned Adipotide as a reference standard for researchers exploring comprehensive targeted fat research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
Adipotide Documented Benefits: 1 Documented Mechanisms
Extended Research Supply
Double the compound for comprehensive targeted adipose research protocols.
How Adipotide Works: Molecular Mechanism & Pathway
Same PDGFR-targeting + KLAKLAK pro-apoptotic adipose vasculature mechanism.
The 1 primary research pathways identified for Adipotide — Extended Research Supply — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that 98.7% purity, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, Adipotide's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
Adipotide is routinely studied alongside Semaglutide and AOD9604 in metabolic & fat loss-focused compound panels. Researchers investigating comprehensive targeted fat research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that supports dose-response and extended studies has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All Adipotide research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- Double supply for comprehensive research
- 98.7% purity
- Supports dose-response and extended studies
Ideal For
- Comprehensive targeted fat research
- Extended adipose vascular studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on Adipotide. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
Double supply for comprehensive research
98.7% purity
Supports dose-response and extended studies
Third-Party Verified Every Batch
Each vial of Adipotide is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
